Pipeline

We pursue innovative therapies that address unmet medical needs, guided by a fundamental understanding of the genetics and underlying biology of the conditions we seek to help treat.

  • Filter by Therapeutic Area:

  • Filter by Modality:

  • Filter by Phase:

¹Trial evaluating an expanded indication of a product which is approved in the United States, Europe and other markets.

²Phase 2 enrollment targeted to begin in Q4 2024.

Updated September 5, 2024

" class="hidden">中国家具网